We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCRX icon
1051
Pacira BioSciences
PCRX
$924M
$971K 0.01%
18,507
FLS icon
1052
Flowserve
FLS
$10.3B
$971K 0.01%
34,032
+302
+0.9% +$8.06K
CARG icon
1053
CarGurus
CARG
$3.38B
$966K 0.01%
38,126
+5,135
+16% +$120K
PRMW
1054
DELISTED
Primo Water Corporation
PRMW
$966K 0.01%
+70,287
New +$788K
TEVA icon
1055
Teva Pharmaceuticals
TEVA
$42.6B
$961K 0.01%
77,953
M icon
1056
Macy's
M
$6.27B
$961K 0.01%
139,613
+59,941
+75% +$369K
TPR icon
1057
Tapestry
TPR
$25.9B
$959K 0.01%
72,209
+1,083
+2% +$15.4K
GEF icon
1058
Greif
GEF
$5.03B
$957K 0.01%
27,814
+630
+2% +$20.7K
CHKP icon
1059
Check Point Software Technologies
CHKP
$13.7B
$956K 0.01%
8,900
+800
+10% +$84.8K
INDB icon
1060
Independent Bank
INDB
$4.05B
$956K 0.01%
14,251
SHOO icon
1061
Steven Madden
SHOO
$3.46B
$953K 0.01%
38,596
+3,105
+9% +$72.6K
PLXS icon
1062
Plexus
PLXS
$7.04B
$945K 0.01%
13,398
+1,239
+10% +$76.9K
COLB icon
1063
Columbia Banking Systems
COLB
$9.18B
$944K 0.01%
33,312
+2,885
+9% +$73.5K
HI
1064
DELISTED
Hillenbrand
HI
$941K 0.01%
34,745
+3,258
+10% +$74K
AA icon
1065
Alcoa
AA
$13.1B
$930K 0.01%
+82,741
New +$740K
DIOD icon
1066
Diodes
DIOD
$4.48B
$929K 0.01%
18,315
ENSG icon
1067
The Ensign Group
ENSG
$10.6B
$928K 0.01%
22,166
+1,194
+6% +$47.4K
EXLS icon
1068
EXL Service
EXLS
$5.36B
$926K 0.01%
73,030
+3,525
+5% +$41.5K
SCL icon
1069
Stepan Co
SCL
$1.48B
$925K 0.01%
9,531
+934
+11% +$87.8K
FATE icon
1070
Fate Therapeutics
FATE
$294M
$923K 0.01%
26,915
ALLO icon
1071
Allogene Therapeutics
ALLO
$683M
$923K 0.01%
21,556
+3,547
+20% +$128K
WGO icon
1072
Winnebago Industries
WGO
$921M
$919K 0.01%
13,793
BBWI icon
1073
Bath & Body Works
BBWI
$3.76B
$914K 0.01%
75,502
+1,453
+2% +$16.2K
AIMC
1074
DELISTED
Altra Industrial Motion Corp
AIMC
$913K 0.01%
28,671
WK icon
1075
Workiva
WK
$4.01B
$907K 0.01%
16,962
+1,341
+9% +$55K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.